<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Front Pediatr</journal-id><journal-id journal-id-type="publisher-id">Front. Pediatr.</journal-id><journal-title-group><journal-title>Frontiers in Pediatrics</journal-title></journal-title-group><issn pub-type="epub">2296-2360</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29662873</article-id><article-id pub-id-type="pmc">5890181</article-id><article-id pub-id-type="doi">10.3389/fped.2018.00052</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pediatrics</subject><subj-group><subject>Clinical Trial</subject></subj-group></subj-group></article-categories><title-group><article-title>Permissive Hypercapnia Results in Decreased Functional Vessel Density in the Skin of Extremely Low Birth Weight Infants</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Puchwein-Schwepcke</surname><given-names>Alexandra Francoise</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1">*</xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/510146"/></contrib><contrib contrib-type="author"><name><surname>Schottmayer</surname><given-names>Kristina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mormanov&#x000e1;</surname><given-names>Zuzana</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Dreyhaupt</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/496260"/></contrib><contrib contrib-type="author"><name><surname>Genzel-Boroviczeny</surname><given-names>Orsolya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thome</surname><given-names>Ulrich H.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><uri xlink:type="simple" xlink:href="http://frontiersin.org/people/u/293258"/></contrib></contrib-group><aff id="aff1"><sup>1</sup><institution>Divsion of Neonatology, Dr. von Hauner Children&#x02019;s Hospital, Ludwig-Maximilians-University</institution>, <addr-line>Munich</addr-line>, <country>Germany</country></aff><aff id="aff2"><sup>2</sup><institution>Institute for Epidemiology and Medical Biometry, University of Ulm</institution>, <addr-line>Ulm</addr-line>, <country>Germany</country></aff><aff id="aff3"><sup>3</sup><institution>Divsion of Neonatology, University Hospital of Leipzig</institution>, <addr-line>Leipzig</addr-line>, <country>Germany</country></aff><author-notes><fn fn-type="edited-by"><p>Edited by: Eugene Dempsey, University College Cork, Ireland</p></fn><fn fn-type="edited-by"><p>Reviewed by: Gerhard Pichler, Medizinische Universit&#x000e4;t Graz, Austria; Kai K&#x000f6;nig, Medicum Wesemlin, Switzerland</p></fn><corresp content-type="corresp" id="cor1">*Correspondence: Alexandra Francoise Puchwein-Schwepcke, <email>alexandra.schwepcke@med.uni-muenchen.de</email></corresp><fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Neonatology, a section of the journal Frontiers in Pediatrics</p></fn></author-notes><pub-date pub-type="epub"><day>13</day><month>3</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>6</volume><elocation-id>52</elocation-id><history><date date-type="received"><day>23</day><month>12</month><year>2017</year></date><date date-type="accepted"><day>23</day><month>2</month><year>2018</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2018 Puchwein-Schwepcke, Schottmayer, Mormanov&#x000e1;, Dreyhaupt, Genzel-Boroviczeny and Thome.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Puchwein-Schwepcke, Schottmayer, Mormanov&#x000e1;, Dreyhaupt, Genzel-Boroviczeny and Thome</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract abstract-type="executive-summary"><sec id="ST1"><title>Background</title><p>Ventilator-induced lung injury with subsequent bronchopulmonary dysplasia remains an important issue in the care of extremely low-birth-weight infants. Permissive hypercapnia has been proposed to reduce lung injury. Hypercapnia changes cerebral perfusion, but its influence on the peripheral microcirculation is unknown.</p></sec><sec id="ST2"><title>Methods</title><p>Data were collected from 12 infants, who were randomized to a permissive high PCO<sub>2</sub> target group (HTG) or a control group (CG). Inclusion criteria were birth weight between 400 and 1,000&#x02009;g, gestational age from 23 to 28 6/7&#x02009;weeks, intubation during the first 24&#x02009;h of life, and no malformations. The PCO<sub>2</sub> target range was increased stepwise in both groups for weaning and was always 15&#x02009;mmHg higher in the HTG than in the CG. Skin microvascular parameters were assessed non-invasively with sidestream dark field imaging on the inner side of the right arm every 24&#x02009;h during the first week of life and on the 14th day of life.</p></sec><sec id="ST3"><title>Results</title><p>Infants in the HTG had significantly higher max. PCO<sub>2</sub> exposure, which was associated with a significantly and progressively reduced functional vessel density (FVD, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01). Moreover, there were significant differences in the diameter distribution over time, with HTG subjects having fewer small vessels but more large vessels.</p></sec><sec id="ST4"><title>Conclusion</title><p>High PCO<sub>2</sub> levels significantly impaired peripheral microcirculation in preterm infants, as shown by a decreased FVD, presumably secondary to peripheral vasoconstriction.</p></sec><sec id="ST5"><title>ISRCTN</title><p>56143743.</p></sec></abstract><kwd-group><kwd>microcirculation</kwd><kwd>hypercapnia</kwd><kwd>extremely low birth weight infants</kwd><kwd>functional vessel density</kwd><kwd>skin perfusion</kwd></kwd-group><funding-group><award-group><funding-source id="cn01">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content></funding-source><award-id rid="cn01">DFG TH626-5/1</award-id></award-group></funding-group><counts><fig-count count="7"/><table-count count="1"/><equation-count count="0"/><ref-count count="53"/><page-count count="9"/><word-count count="5361"/></counts></article-meta></front><body><sec sec-type="introduction" id="S1"><title>Introduction</title><p>Most extremely low-birth-weight infants (&#x0003c;1,000&#x02009;g) require respiratory assistance after birth, leading to bronchopulmonary dysplasia (BPD), a chronic form of lung disease (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). Permissive hypercapnia is a strategy of tolerating higher PCO<sub>2</sub> levels for the benefit of less aggressive ventilation and therefore less mechanical trauma to the lung (<xref rid="B3" ref-type="bibr">3</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>). In randomized trials, ventilatory intensities were reduced but resulted in only marginal positive effects on clinical outcome (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B8" ref-type="bibr">8</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>). Concerns about possible adverse effects such as intraventricular hemorrhage with consecutive developmental impairment, as suggested by retrospective data (<xref rid="B12" ref-type="bibr">12</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>), have not been substantiated in randomized controlled trials (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B8" ref-type="bibr">8</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>). We know that hypercapnia causes dilatation of cerebral arterioles with possibly increased risk of intracranial bleeding (<xref rid="B16" ref-type="bibr">16</xref>). On the level of the microcirculation, hypoxia and hypercapnia lead to an increase in perfusion in the cerebral cortex of the rat (<xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>).</p><p>In the past 10 years, we have learned that disturbances in the microcirculation have profound effects on outcome. In sepsis, for example, a persistent decrease in functional vessel density (FVD) is indicative of poor survival (<xref rid="B19" ref-type="bibr">19</xref>, <xref rid="B20" ref-type="bibr">20</xref>). Changes in the microcirculation were also observed in many different settings such as subarachnoid hemorrhage, congenital heart disease, or myocardial ischemia (<xref rid="B21" ref-type="bibr">21</xref>&#x02013;<xref rid="B23" ref-type="bibr">23</xref>). In the preterm infant, a persistent ductus arteriosus (PDA) significantly changes the microcirculation of the skin (<xref rid="B24" ref-type="bibr">24</xref>). In preterm hypotensive newborns, FVD in the periphery was significantly elevated in comparison to normotensive infants, suggesting a redistribution of microvascular flow as an underlying mechanism for hypotension (<xref rid="B25" ref-type="bibr">25</xref>).</p><p>Therefore, the microcirculation is an important, but underrecognized physiologic function with possible impact on important clinical outcome parameters. Furthermore, the microcirculation may be influenced by PCO<sub>2</sub>. We sought to measure the microcirculation in very preterm infants participating in a multicenter randomized controlled trial of different PCO<sub>2</sub> target ranges (PHELBI) (<xref rid="B10" ref-type="bibr">10</xref>). The skin of the preterm infants is a specific and easily accessible organ to observe changes in the microcirculation. Our hypothesis was that the cutaneous microcirculation might be affected by higher PCO<sub>2</sub> levels during permissive hypercapnia regarding FVD, diameter distribution, and quality of flow.</p></sec><sec sec-type="materials|methods" id="S2"><title>Materials and Methods</title><p>This study was part of the randomized, prospective multicenter hypercapnia study (PHELBI, ISRCTN 56143743) (<xref rid="B10" ref-type="bibr">10</xref>). Infants with gestational ages between 23 and 28 6/7&#x02009;weeks and birth weights between 400 and 1,000&#x02009;g, who were intubated during the first 24&#x02009;h, were randomized within the next 12&#x02009;h to either a high PCO<sub>2</sub> target group (HTG) or a control group (CG) after written parental consent. Exclusion criteria were congenital malformations, chromosomal aberrations, and severe asphyxia [pH&#x02009;&#x0003c;&#x02009;7.0 and heart rate (HR)&#x02009;&#x0003c;&#x02009;100/min at 10&#x02009;min of life]. All infants who participated in the PHELBI trial at our center within a predefined time frame of 18&#x02009;months were included in this study.</p><p>During the first 14&#x02009;days of life, the PCO<sub>2</sub> target ranges were increased stepwise with the target range in the HTG always 15&#x02009;mmHg higher than in the CG. PCO<sub>2</sub> levels were kept between 55 and 65&#x02009;mmHg in the HTG and 40 and 50&#x02009;mmHg in the CG during the first 3&#x02009;days, increased to 60&#x02013;70&#x02009;mmHg (HTG) and 45&#x02013;55&#x02009;mmHg (CG) on the fourth day, and increased to 65&#x02013;75&#x02009;mmHg (HTG) and 50&#x02013;60&#x02009;mmHg (CG) again on the seventh day until extubation or peak inspiratory pressure &#x0003c;12&#x02009;cm H<sub>2</sub>O or day 14. At our center, the skin microcirculation of a subgroup of randomized infants was evaluated as single-center substudy. The institutional review board of the Medical Faculty of Ludwig Maximilians University of Munich approved the study protocol and the consent forms, and all parents granted written informed consent.</p><p>Sidestream dark field (SDF) imaging with the handheld video microscope &#x0201c;MicroScan&#x0201d; (Microvision Medical, Wallingford, Pennsylvania) with a five times magnification was used for the assessment of the microcirculation. Monochromatic green light (530&#x02009;nm) emitted from LEDs, surrounding a light guide, is absorbed by hemoglobin in the erythrocytes and reflected by other tissues or structures. The result is a real-time video of perfused vessels to a depth of 3&#x02009;mm, thus producing a functional video of the microcirculation. SDF imaging has been validated against conventional capillary microscopy in various studies (<xref rid="B26" ref-type="bibr">26</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>). We obtained sequences of 15&#x02009;s on three different areas on the right inner upper arm. The sublingual region usually preferred for SDF imaging in adults is not feasible in preterm infants. In previous studies, the upper arm has been shown to be easily accessible and to provide a good image quality (<xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B31" ref-type="bibr">31</xref>). To reduce artifacts by lanugo hair, we chose the inner side of the arm. Since a PDA influences the skin microcirculation, we consistently used only the right arm to avoid the effects of PDA as a confounder (<xref rid="B24" ref-type="bibr">24</xref>).</p><p>Measurements started on the first day of life and continued over the first week in 24-h intervals, and the last measurement was obtained on the fourteenth day of life. All measurements were done by one investigator (KS). All video loops were analyzed offline with the microvision analysis software, which offers a semiautomatic analysis. Vessels are automatically detected on the screen, but individual corrections for artifacts such as hair are possible. FVD, which represents total vessel length in millimeter per image area in square millimeter, as well as the distribution of vessel diameters is subsequently calculated. The latter results in the representation of small (&#x0003c;10&#x02009;&#x003bc;m), medium (10&#x02013;20&#x02009;&#x000b5;m), and large (20&#x02013;100&#x02009;&#x000b5;m) vessels as a percentage of the total vessel length. Moreover, quality of flow was analyzed, classifying vessels of a quadrant into vessels with &#x0201c;no flow,&#x0201d; &#x0201c;intermittent flow,&#x0201d; &#x0201c;sluggish flow,&#x0201d; &#x0201c;continuous flow,&#x0201d; and &#x0201c;hyperdynamic flow.&#x0201d; Normal flow is defined as continuous flow and hyperdynamic flow as extremely fast flow. No flow and intermittent and sluggish flow stand for different stages of hypodynamic and thus pathological flow. Flow classification was undertaken on the third, fourth, sixth, seventh, and fourteenth day of life and expressed as percentage of vessels with the respective quality of flow. All video analyses were performed with the investigator blinded to patient, treatment, and time point.</p><p>Simple statistical analyses were performed with GraphPadPrism 5 (GraphPad Software Inc., La Jolla, CA, USA). For each time point, three video scans per arm were analyzed, and the mean value of a variable was used for statistical analysis. To compare both groups over time, we used linear mixed effects regression models to account for the dependencies of measurements within each infant (fitted with proc mixed, SAS software version 9.4, SAS Institute, Cary, NC, USA). Group comparisons for categorical variables were performed using the chi-square test or Fisher&#x02019;s exact test as appropriate.</p><p>For unpaired comparisons between the two groups, the Mann&#x02013;Whitney <italic>U</italic> test was used for non-parametric data. For paired comparisons, the Wilcoxon signed-rank test was used.</p><p>To consider the development of PCO<sub>2</sub> exposure between both groups, a further linear mixed effects regression model was used. For other laboratory values (hematocrit, lactate, and CRP), we compared minimal and maximal values over the observation period with the Mann&#x02013;Whitney <italic>U</italic> test. Because of the exploratory nature of our study, the results of the statistical tests should not be interpreted as confirmatory. An adjustment for multiple testing was not done. <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05 was considered as statistically significant.</p><p>The PCO<sub>2</sub> levels were monitored by blood gas analyses, using arterial blood if available, or capillary blood. CRP levels, hemoglobin levels, medication, and blood transfusions were extracted from the charts. Vital signs were recorded before the start of each microcirculation measurement.</p></sec><sec id="S3"><title>Results</title><sec id="S3-1"><title>Clinical Variables</title><p>Twelve preterm infants were enrolled in our study (six from each randomization group, see Figure <xref ref-type="fig" rid="F1">1</xref>). Gender and birth weight distribution and other variables were similar (Table <xref ref-type="table" rid="T1">1</xref>). One infant of the HTG group had to be excluded, as it was extubated on day 2 of life. Another infant of the HTG group died on day 4 of life. Microcirculatory and clinical values of this infant were included as available. Ventilation parameters such as mean airway pressure, positive end-expiratory pressure (PEEP), positive inspiratory pressure (PIP), high-frequency oscillation amplitude, and frequency tended to be lower in the HTG group, as expected, but not significantly. PCO<sub>2</sub> values were significantly higher (Figure <xref ref-type="fig" rid="F2">2</xref>; Table <xref ref-type="table" rid="T1">1</xref>). Incubator temperature and humidity, HR, and blood pressure did not differ. Other laboratory values, including hemoglobin, hematocrit, lactate, and CRP, did not differ significantly.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>A total number of 12 patients could be included to the study as illustrated in the Consort flow diagram.</p></caption><graphic xlink:href="fped-06-00052-g001"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Clinical data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">High PCO<sub>2</sub> target group (<italic>n</italic>&#x02009;=&#x02009;5)</th><th valign="top" align="center" rowspan="1" colspan="1">Control group (<italic>n</italic>&#x02009;=&#x02009;6)</th><th valign="top" align="center" rowspan="1" colspan="1"><italic>p</italic> Value</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Gestational age (weeks)<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">24 2/7 (23 3/7&#x02013;27 6/7)</td><td align="center" valign="top" rowspan="1" colspan="1">25 4/7 (24 3/7&#x02013;27 2/7)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Birth weight (g)<xref ref-type="table-fn" rid="tfn1"><sup>a</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">685 (590&#x02013;990)</td><td align="center" valign="top" rowspan="1" colspan="1">712 (490&#x02013;885)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Male gender</td><td align="center" valign="top" rowspan="1" colspan="1">3 (60%)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (50%)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Betamethasone</td><td align="center" valign="top" rowspan="1" colspan="1">5 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Tracheal ventilation on day 14</td><td align="center" valign="top" rowspan="1" colspan="1">3 (75%)</td><td align="center" valign="top" rowspan="1" colspan="1">6 (100%)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Average PCO<sub>2</sub> exposition<xref ref-type="table-fn" rid="tfn2"><sup>b</sup></xref></td><td align="center" valign="top" rowspan="1" colspan="1">56 (53&#x02013;63)</td><td align="center" valign="top" rowspan="1" colspan="1">51 (48&#x02013;54)</td><td align="center" valign="top" rowspan="1" colspan="1">0.03</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Catecholamine treatment</td><td align="center" valign="top" rowspan="1" colspan="1">1 (20%)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (80%)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Min. Hct%</td><td align="center" valign="top" rowspan="1" colspan="1">31 (29&#x02013;35)</td><td align="center" valign="top" rowspan="1" colspan="1">30 (28&#x02013;39)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Max. lactate (mmol/l)</td><td align="center" valign="top" rowspan="1" colspan="1">2.6 (1.3&#x02013;11.6)</td><td align="center" valign="top" rowspan="1" colspan="1">3.2 (1.7&#x02013;5.8)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Max. CRP (mg/l)</td><td align="center" valign="top" rowspan="1" colspan="1">0.7 (0.3&#x02013;3.8)</td><td align="center" valign="top" rowspan="1" colspan="1">2.3 (0.2&#x02013;8.2)</td><td align="center" valign="top" rowspan="1" colspan="1">n.s.</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><p><italic><sup>a</sup>Median (minimum&#x02013;maximum), Mann&#x02013;Whitney <italic>U</italic> test</italic>.</p></fn><fn id="tfn2"><p><italic><sup>b</sup>Median (minimum&#x02013;maximum), Wilcoxon rank sum test</italic>.</p></fn><p><italic>All others: <italic>n</italic> (%), Fisher&#x02019;s exact test</italic>.</p></table-wrap-foot></table-wrap><fig id="F2" position="float"><label>Figure 2</label><caption><p>PCO<sub>2</sub> minima and maxima in the high PCO<sub>2</sub> target group (HTG) and control group (CG) over the course of 14&#x02009;days after birth. Minimum and maximum values of all patients are presented as mean values with SDs. PCO<sub>2</sub> target levels were stepwise increased on the fourth and seventh day of life. As intended, PCO<sub>2</sub> levels were higher in the HTG.</p></caption><graphic xlink:href="fped-06-00052-g002"/></fig></sec><sec id="S3-2"><title>Microcirculatory Variables</title><p>Images showed similar vasculature at baseline, but declining vessel density toward the end of the study in the HTG (Figure <xref ref-type="fig" rid="F3">3</xref>). Similar results were determined by the quantitative evaluation.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Typical image of the microcirculation. <bold>(A)</bold> Day 1 control group, <bold>(B)</bold> day 14 control group, <bold>(C)</bold> day 1 high PCO<sub>2</sub> target group, and <bold>(D)</bold> day 14 high PCO<sub>2</sub> target group.</p></caption><graphic xlink:href="fped-06-00052-g003"/></fig><sec id="S3-2-1"><title>Functional Vessel Density</title><p>Functional vessel density did not differ at baseline between HTG and CG, but decreased significantly over the first week in the HTG and remained lower until the end of the study (Figure <xref ref-type="fig" rid="F4">4</xref>), compared to CG. The comparison between groups and the time effect was significant (both <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01). Vessel surface (VS) was also significantly lower in the HTG group over time (Figure <xref ref-type="fig" rid="F5">5</xref>, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 for the between-group comparison and <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 for the time effect).</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Functional vessel density (FVD) over the course of 14&#x02009;days. Mean and SD are shown. Overall, FVD was significantly lower in the high PCO<sub>2</sub> target group (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 by a linear mixed effects regression model) and time dependent (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01).</p></caption><graphic xlink:href="fped-06-00052-g004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><p>Vessel surface (VS) over the course of 14&#x02009;days. Mean and SD are shown. Overall, VS was significantly lower in the high PCO<sub>2</sub> target group (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 for the between groups comparison, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 for the time effect).</p></caption><graphic xlink:href="fped-06-00052-g005"/></fig></sec><sec id="S3-2-2"><title>Diameter</title><p>Most detected vessels were small with diameters &#x0003c;10&#x02009;&#x000b5;m and varied between 60 and 80% of vessel density with no significant difference between the groups at baseline. In the HTG group, the proportion of small vessels significantly decreased (Figure <xref ref-type="fig" rid="F6">6</xref>), and therefore, the proportion of medium and large vessels increased significantly over time (Figure <xref ref-type="fig" rid="F7">7</xref>). This resulted in a significant difference between groups in the vessel distribution (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01) with a significant time effect (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05).</p><fig id="F6" position="float"><label>Figure 6</label><caption><p>Distribution of small vessels over the course of 14&#x02009;days. Mean and SD are shown. In the high PCO<sub>2</sub> target group, the proportion of small vessels significantly decreased resulting in a significant difference between groups in the vessel distribution (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01).</p></caption><graphic xlink:href="fped-06-00052-g006"/></fig><fig id="F7" position="float"><label>Figure 7</label><caption><p>Distribution of medium and large vessels over the course of 14&#x02009;days. Mean and SD are shown. In the high PCO<sub>2</sub> target group (HTG), the proportion of medium and large vessels significantly increased over time (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05), resulting in a significant difference between groups in the vessel distribution (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01).</p></caption><graphic xlink:href="fped-06-00052-g007"/></fig></sec><sec id="S3-2-3"><title>Flow</title><p>The flow in most vessels was continuous, and only a small fraction &#x0003c;6% had no flow in both groups. There were no significant differences between both groups over the time observed. The stepwise increases of PCO<sub>2</sub> targets on days 4 and 7 were not consistently followed by temporary increases of flow to hyperdynamic levels in all patients (data not shown).</p></sec></sec></sec><sec sec-type="discussion" id="S4"><title>Discussion</title><p>This study demonstrates that 14&#x02009;days of permissive hypercapnia with relatively high PCO<sub>2</sub> targets as used in this study have a significant impact on the microcirculation of the skin, compared to the CG with only mildly elevated targets. We demonstrated a significant decrease in FVD, whereas FVD remained constant in the CG. Thus, hypercapnia significantly reduced skin perfusion. The decrease is more prominent in the second week of permissive hypercapnia. This suggests a long-term influence of higher PCO<sub>2</sub> levels on skin capillaries. This is the first study to evaluate the influence of hypercapnia on the microcirculation of preterm infants over a longer time period (<xref rid="B16" ref-type="bibr">16</xref>&#x02013;<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B32" ref-type="bibr">32</xref>&#x02013;<xref rid="B43" ref-type="bibr">43</xref>). Moreover, we demonstrate significant changes in the diameter distribution with a shift toward larger vessels in the HTG group. At the same time, other clinical parameters as well as ventilation parameters such as PIP and PEEP did not differ between both groups. Thus, the only difference between both groups relevant for our measurements can be seen in the partial pressure of arterial CO<sub>2</sub>.</p><p>Peripheral oxygenation is essential for preserving organ function (<xref rid="B44" ref-type="bibr">44</xref>). Macrocirculatory parameters are only a poor indicator for tissue oxygen delivery (<xref rid="B19" ref-type="bibr">19</xref>). SDF imaging provides a non-invasive technique to visualize peripheral vasoregulation by using a microscope at the bedside.</p><p>The reduction of FVD and VS may be the result of a PCO<sub>2</sub>-dependent redistribution of blood flow. Respiratory-induced changes in the partial pressure of arterial CO<sub>2</sub> also play a major role in the regulation of cerebral blood flow (<xref rid="B45" ref-type="bibr">45</xref>). Hypercapnia leads to vasodilatation of cerebral arterioles, whereas hypocapnia leads to vasoconstriction and a subsequent decrease in cerebral arterial flow (<xref rid="B46" ref-type="bibr">46</xref>). Therefore, one would have expected a higher FVD in the HTG group, but the opposite effect was found. One possible explanation may be concurrent hypercapnia-induced vasodilatation in deeper areas of the body, including, but not limited, the brain, which may have drawn blood supply away from the skin, leading to a compensatory vasoconstriction and thus explaining the effects observed in this study.</p><p>Alternatively, high PCO<sub>2</sub> may have a direct negative effect on skin perfusion. Both suggested mechanisms would lead to a redistribution of the blood volume toward larger vessels in the deeper areas.</p><p>Another possible explanation for a reduction in FVD and VS may be the so-called Bohr effect. Raised PCO<sub>2</sub> levels and a low pH reduce the oxygen affinity of hemoglobin and facilitate oxygen unloading, thus enhancing oxygen diffusion from hemoglobin to the tissues (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B34" ref-type="bibr">34</xref>). Therefore, the lower FVD does not need to be a negative effect; it could also be a sign of better tissue oxygenation while reducing the need for perfused blood vessels.</p><p>A fourth possible explanation for the reduction in FVD may be vasodilation due to high PCO<sub>2</sub> values, which could explain the larger proportion of medium and large vessels observed in our HTG group. As a compensatory mechanism, small vessels would constrict and would result in a reduced overall FVD and VS due to hypercapnia.</p><p>Therefore, the significant changes in diameter distribution seem to be another interesting finding in our study. After birth, both groups showed a similar distribution of vessel diameter. When analyzed on the fourteenth day, the fraction of small vessels had decreased in the HTG, while it increased in the CG. In return, medium and large vessels were more prominent in the HT group.</p><p>Komori et al. (<xref rid="B36" ref-type="bibr">36</xref>) described proportionate increasing diameters and velocity while increasing PCO<sub>2</sub> up to levels of 80&#x02009;mmHg in rabbits. Hudetz et al. (<xref rid="B18" ref-type="bibr">18</xref>) obtained similar results when studying the effects of hypercapnia in the capillaries of the rat cerebral cortex. The increasing diameters are consistent with our observation that the proportion of medium and large vessels increases with higher PCO<sub>2</sub> levels. However, we cannot confirm the increased velocity, because even though the fraction of hyperdynamic flow appeared to increase with higher PCO<sub>2</sub> targets, this did not reach statistical significance in our study. In sepsis models, similar microcirculatory changes indicated a poorer outcome (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>).</p><p>Due to the strict exclusion criteria and the very time-consuming methods and analyses, our study population was rather small and random errors cannot be ruled out. Another limitation might be that analyses of the flow were performed semiquantitatively.</p><p>The microcirculation is influenced by various factors, such as hematocrit and hemoglobin level, incubator temperature, blood transfusions, infections, PDA, and gender (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B31" ref-type="bibr">31</xref>, <xref rid="B49" ref-type="bibr">49</xref>&#x02013;<xref rid="B52" ref-type="bibr">52</xref>). There were no significant differences in our groups concerning these possible confounders. Blood pressure and HR showed no significant or only individual influence on the microcirculation in previous studies (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B53" ref-type="bibr">53</xref>) and were similar in both groups. Catecholamine treatment has been shown to increase FVD in premature infants (<xref rid="B25" ref-type="bibr">25</xref>), which might be a possible confounder in our results. Catecholamine treatment appeared to occur more frequently in the CG than the HTG, although this has not been statistically significant. However, catecholamines were given only for a few days. Effects of catecholamine treatment on the microcirculation have been demonstrated only in the first 6&#x02009;h after birth and not after discontinuation of the treatment. Therefore, we do not think that catecholamine treatment confounded our results, showing long-term reduction in FVD seen in the HTG.</p><p>Another possible limitation is the lack of measurements between the seventh and the fourteenth day. We had decided beforehand to concentrate on the immediate effects after elevation of PCO<sub>2</sub> as well as the long-term effects under treatment with permissive hypercapnia and not to focus on single data points.</p><p>Vascular development is a key process in lung development, and impaired vascular development has been linked to the emergence of BPD. Due to our small patient group, we were unable to detect significant differences in clinical outcome. However, if we look at the missing benefit or even worsened pulmonary outcome of the patients of the HTG group in the PHELBI trial (<xref rid="B10" ref-type="bibr">10</xref>), we speculate that the pulmonary outcome may have been linked to the differences in microcirculation. If lung vessels respond in the same manner as skin vessels, the reduced vessel density after prolonged hypercapnia observed in this study may be one possible additional mechanism why permissive hypercapnia as performed in this study has not fulfilled the hope of reducing the incidence of BPD (<xref rid="B10" ref-type="bibr">10</xref>). Although flow was not significantly impaired in our study, which might be due to the small number of patients, a reduction in FVD results in a pronounced transformation of microvascular architecture, which could be an important pathophysiological mechanism in the genesis of BPD.</p><p>In conclusion, our study showed a significant decrease in FVD after long-term treatment with high PCO<sub>2</sub> targets, possibly due to flow redistribution toward larger vessels in deeper areas. The microcirculation is a sensitive parameter that reacts to changes in multiple diseases or conditions. In our case, it provided a different perspective on the benefits and disadvantages reported under permissive hypercapnia (<xref rid="B9" ref-type="bibr">9</xref>) and should be further explored in larger studies.</p></sec><sec id="S5"><title>Ethics Statement</title><p>This study was carried out in accordance with the recommendations of the institutional review board of the Ludwig Maximilians University with written informed consent from all subjects. All subjects gave written informed consent in accordance with the Declaration of Helsinki. The protocol was approved by the institutional review board of the Ludwig Maximilians University.</p></sec><sec id="S6"><title>Author Contributions</title><p>AP-S, KS, ZM, OG, and UT conceived and planned the trial and the measurements. KS and ZM carried out the measurements. KS did the analysis of the microcirculatory videos and clinical data. AP-S, KS, ZM, OG, JD, and UT contributed to the interpretation of the results. JD, UT, and AP-S performed the statistical analyses. AP-S took the lead in writing the manuscript. All authors provided critical feedback and helped shape the investigations, analyses, and the manuscript.</p></sec><sec id="S7"><title>Conflict of Interest Statement</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>The study was part of the dissertation of KS.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> The main trial was funded by taxpayer funds through the DFG (Deutsche Forschungsgemeinschaft DFG TH626-5/1).</p></fn></fn-group><sec id="S8"><title>Abbreviations</title><p>A/C, assisted/controlled; AUC, area under the curve; BPD, bronchopulmonary dysplasia; ELBI, extremely low birth weight infant; SDF, sidestream dark field; FVD, functional vessel density; HTG, high PCO<sub>2</sub> target group; HFO, high-frequency oscillation; HR, heart rate; IVH, intraventricular hemorrhage; MAP, mean airway pressure; CG, control group; OPS, orthogonal polarization spectral; PDA, persistent ductus arteriosus; PEEP, positive end-expiratory pressure; PIP, positive inspiratory pressure; SIMV, synchronized intermittent mandatory ventilation; VS, vessel surface.</p></sec><ref-list><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christou</surname><given-names>H</given-names></name><name><surname>Brodsky</surname><given-names>D</given-names></name></person-group>. <article-title>Lung injury and bronchopulmonary dysplasia in newborn infants</article-title>. <source>J Intensive Care Med</source> (<year>2005</year>) <volume>20</volume>(<issue>2</issue>):<fpage>76</fpage>&#x02013;<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1177/0885066604273494</pub-id><pub-id pub-id-type="pmid">15855220</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suguihara</surname><given-names>C</given-names></name><name><surname>Lessa</surname><given-names>AC</given-names></name></person-group>
<article-title>[Strategies to minimize lung injury in extremely low birth weight infants]</article-title>. <source>J Pediatr (Rio J)</source> (<year>2005</year>) <volume>81</volume>(<issue>1 Suppl</issue>):<fpage>S69</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="pmid">15809700</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagen</surname><given-names>EW</given-names></name><name><surname>Sadek-Badawi</surname><given-names>M</given-names></name><name><surname>Carlton</surname><given-names>DP</given-names></name><name><surname>Palta</surname><given-names>M</given-names></name></person-group>. <article-title>Permissive hypercapnia and risk for brain injury and developmental impairment</article-title>. <source>Pediatrics</source> (<year>2008</year>) <volume>122</volume>(<issue>3</issue>):<fpage>e583</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1542/peds.2008-1016</pub-id><pub-id pub-id-type="pmid">18762492</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>Honan</surname><given-names>D</given-names></name><name><surname>Hopkins</surname><given-names>N</given-names></name><name><surname>Hyvelin</surname><given-names>JM</given-names></name><name><surname>Boylan</surname><given-names>JF</given-names></name><name><surname>McLoughlin</surname><given-names>P</given-names></name></person-group>. <article-title>Hypercapnic acidosis attenuates endotoxin-induced acute lung injury</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2004</year>) <volume>169</volume>(<issue>1</issue>):<fpage>46</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200205-394OC</pub-id><pub-id pub-id-type="pmid">12958048</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laffey</surname><given-names>JG</given-names></name><name><surname>Jankov</surname><given-names>RP</given-names></name><name><surname>Engelberts</surname><given-names>D</given-names></name><name><surname>Tanswell</surname><given-names>AK</given-names></name><name><surname>Post</surname><given-names>M</given-names></name><name><surname>Lindsay</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>Effects of therapeutic hypercapnia on mesenteric ischemia-reperfusion injury</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2003</year>) <volume>168</volume>(<issue>11</issue>):<fpage>1383</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.2108078</pub-id><pub-id pub-id-type="pmid">14644926</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mariani</surname><given-names>G</given-names></name><name><surname>Cifuentes</surname><given-names>J</given-names></name><name><surname>Carlo</surname><given-names>WA</given-names></name></person-group>. <article-title>Randomized trial of permissive hypercapnia in preterm infants</article-title>. <source>Pediatrics</source> (<year>1999</year>) <volume>104</volume>(<issue>5 Pt 1</issue>):<fpage>1082</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1542/peds.104.5.1082</pub-id><pub-id pub-id-type="pmid">10545551</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>SE</given-names></name><name><surname>Kregenow</surname><given-names>DA</given-names></name><name><surname>Lamm</surname><given-names>WJ</given-names></name><name><surname>Starr</surname><given-names>IR</given-names></name><name><surname>Chi</surname><given-names>EY</given-names></name><name><surname>Hlastala</surname><given-names>MP</given-names></name></person-group>. <article-title>Hypercapnic acidosis is protective in an in vivo model of ventilator-induced lung injury</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2002</year>) <volume>166</volume>(<issue>3</issue>):<fpage>403</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200112-117OC</pub-id><pub-id pub-id-type="pmid">12153979</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>AR</given-names></name></person-group>
<article-title>High-frequency oscillatory ventilation to prevent bronchopulmonary dysplasia &#x02013; are we there yet?</article-title>
<source>N Engl J Med</source> (<year>2002</year>) <volume>347</volume>(<issue>9</issue>):<fpage>682</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMe020080</pub-id><pub-id pub-id-type="pmid">12200557</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thome</surname><given-names>UH</given-names></name><name><surname>Carroll</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>TJ</given-names></name><name><surname>Johnson</surname><given-names>RB</given-names></name><name><surname>Roane</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Outcome of extremely preterm infants randomized at birth to different PaCO2 targets during the first seven days of life</article-title>. <source>Biol Neonate</source> (<year>2006</year>) <volume>90</volume>(<issue>4</issue>):<fpage>218</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1159/000092723</pub-id><pub-id pub-id-type="pmid">16636534</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thome</surname><given-names>UH</given-names></name><name><surname>Genzel-Boroviczeny</surname><given-names>O</given-names></name><name><surname>Bohnhorst</surname><given-names>B</given-names></name><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Fuchs</surname><given-names>H</given-names></name><name><surname>Rohde</surname><given-names>O</given-names></name><etal/></person-group>
<article-title>Permissive hypercapnia in extremely low birthweight infants (PHELBI): a randomised controlled multicentre trial</article-title>. <source>Lancet Respir Med</source> (<year>2015</year>) <volume>3</volume>(<issue>7</issue>):<fpage>534</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="doi">10.1016/S2213-2600(15)00204-0</pub-id><pub-id pub-id-type="pmid">26088180</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Network SSGotEKSNNR</collab><name><surname>Carlo</surname><given-names>WA</given-names></name><name><surname>Finer</surname><given-names>NN</given-names></name><name><surname>Walsh</surname><given-names>MC</given-names></name><name><surname>Rich</surname><given-names>W</given-names></name><name><surname>Gantz</surname><given-names>MG</given-names></name><etal/></person-group>
<article-title>Target ranges of oxygen saturation in extremely preterm infants</article-title>. <source>N Engl J Med</source> (<year>2010</year>) <volume>362</volume>(<issue>21</issue>):<fpage>1959</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMoa0911781</pub-id><pub-id pub-id-type="pmid">20472937</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fabres</surname><given-names>J</given-names></name><name><surname>Carlo</surname><given-names>WA</given-names></name><name><surname>Phillips</surname><given-names>V</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Ambalavanan</surname><given-names>N</given-names></name></person-group>. <article-title>Both extremes of arterial carbon dioxide pressure and the magnitude of fluctuations in arterial carbon dioxide pressure are associated with severe intraventricular hemorrhage in preterm infants</article-title>. <source>Pediatrics</source> (<year>2007</year>) <volume>119</volume>(<issue>2</issue>):<fpage>299</fpage>&#x02013;<lpage>305</lpage>.<pub-id pub-id-type="doi">10.1542/peds.2006-2434</pub-id><pub-id pub-id-type="pmid">17272619</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>JR</given-names></name><name><surname>Gauss</surname><given-names>CH</given-names></name><name><surname>Williams</surname><given-names>DK</given-names></name></person-group>. <article-title>The effects of hypercapnia on cerebral autoregulation in ventilated very low birth weight infants</article-title>. <source>Pediatr Res</source> (<year>2005</year>) <volume>58</volume>(<issue>5</issue>):<fpage>931</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1203/01.pdr.0000182180.80645.0c</pub-id><pub-id pub-id-type="pmid">16257928</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiser</surname><given-names>JR</given-names></name><name><surname>Tilford</surname><given-names>JM</given-names></name><name><surname>Simpson</surname><given-names>PM</given-names></name><name><surname>Salhab</surname><given-names>WA</given-names></name><name><surname>Rosenfeld</surname><given-names>CR</given-names></name></person-group>. <article-title>Hospital survival of very-low-birth-weight neonates from 1977 to 2000</article-title>. <source>J Perinatol</source> (<year>2004</year>) <volume>24</volume>(<issue>6</issue>):<fpage>343</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1038/sj.jp.7211113</pub-id><pub-id pub-id-type="pmid">15116138</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>JD</given-names></name><name><surname>Carlo</surname><given-names>WA</given-names></name></person-group>. <article-title>Safety and effectiveness of permissive hypercapnia in the preterm infant</article-title>. <source>Curr Opin Pediatr</source> (<year>2007</year>) <volume>19</volume>(<issue>2</issue>):<fpage>142</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1097/MOP.0b013e3280895e12</pub-id><pub-id pub-id-type="pmid">17496755</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harkin</surname><given-names>CP</given-names></name><name><surname>Schmeling</surname><given-names>WT</given-names></name><name><surname>Kampine</surname><given-names>JP</given-names></name><name><surname>Farber</surname><given-names>NE</given-names></name></person-group>. <article-title>The effects of hyper- and hypocarbia on intraparenchymal arterioles in rat brain slices</article-title>. <source>Neuroreport</source> (<year>1997</year>) <volume>8</volume>(<issue>8</issue>):<fpage>1841</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1097/00001756-199705260-00010</pub-id><pub-id pub-id-type="pmid">9223062</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bereczki</surname><given-names>D</given-names></name><name><surname>Wei</surname><given-names>L</given-names></name><name><surname>Otsuka</surname><given-names>T</given-names></name><name><surname>Hans</surname><given-names>FJ</given-names></name><name><surname>Acuff</surname><given-names>V</given-names></name><name><surname>Patlak</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Hypercapnia slightly raises blood volume and sizably elevates flow velocity in brain microvessels</article-title>. <source>Am J Physiol</source> (<year>1993</year>) <volume>264</volume>(<issue>5 Pt 2</issue>):<fpage>H1360</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">8498549</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudetz</surname><given-names>AG</given-names></name><name><surname>Biswal</surname><given-names>BB</given-names></name><name><surname>Feher</surname><given-names>G</given-names></name><name><surname>Kampine</surname><given-names>JP</given-names></name></person-group>. <article-title>Effects of hypoxia and hypercapnia on capillary flow velocity in the rat cerebral cortex</article-title>. <source>Microvasc Res</source> (<year>1997</year>) <volume>54</volume>(<issue>1</issue>):<fpage>35</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1006/mvre.1997.2023</pub-id><pub-id pub-id-type="pmid">9245642</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Backer</surname><given-names>D</given-names></name><name><surname>Creteur</surname><given-names>J</given-names></name><name><surname>Preiser</surname><given-names>JC</given-names></name><name><surname>Dubois</surname><given-names>MJ</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group>. <article-title>Microvascular blood flow is altered in patients with sepsis</article-title>. <source>Am J Respir Crit Care Med</source> (<year>2002</year>) <volume>166</volume>(<issue>1</issue>):<fpage>98</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="doi">10.1164/rccm.200109-016OC</pub-id><pub-id pub-id-type="pmid">12091178</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakr</surname><given-names>Y</given-names></name><name><surname>Dubois</surname><given-names>MJ</given-names></name><name><surname>De Backer</surname><given-names>D</given-names></name><name><surname>Creteur</surname><given-names>J</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group>. <article-title>Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock</article-title>. <source>Crit Care Med</source> (<year>2004</year>) <volume>32</volume>(<issue>9</issue>):<fpage>1825</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1097/01.CCM.0000138558.16257.3F</pub-id><pub-id pub-id-type="pmid">15343008</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chierego</surname><given-names>M</given-names></name><name><surname>Verdant</surname><given-names>C</given-names></name><name><surname>De Backer</surname><given-names>D</given-names></name></person-group>. <article-title>Microcirculatory alterations in critically ill patients</article-title>. <source>Minerva Anestesiol</source> (<year>2006</year>) <volume>72</volume>(<issue>4</issue>):<fpage>199</fpage>&#x02013;<lpage>205</lpage>.<pub-id pub-id-type="pmid">16570031</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbers</surname><given-names>PW</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group>
<article-title>Mechanisms of critical illness &#x02013; classifying microcirculatory flow abnormalities in distributive shock</article-title>. <source>Crit Care</source> (<year>2006</year>) <volume>10</volume>(<issue>4</issue>):<fpage>221</fpage><pub-id pub-id-type="doi">10.1186/cc4568</pub-id><pub-id pub-id-type="pmid">16879732</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verdant</surname><given-names>C</given-names></name><name><surname>De Backer</surname><given-names>D</given-names></name></person-group>. <article-title>How monitoring of the microcirculation may help us at the bedside</article-title>. <source>Curr Opin Crit Care</source> (<year>2005</year>) <volume>11</volume>(<issue>3</issue>):<fpage>240</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1097/01.ccx.0000158849.94225.11</pub-id><pub-id pub-id-type="pmid">15928473</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiedl</surname><given-names>S</given-names></name><name><surname>Schwepcke</surname><given-names>A</given-names></name><name><surname>Weber</surname><given-names>F</given-names></name><name><surname>Genzel-Boroviczeny</surname><given-names>O</given-names></name></person-group>. <article-title>Microcirculation in preterm infants: profound effects of patent ductus arteriosus</article-title>. <source>J Pediatr</source> (<year>2010</year>) <volume>156</volume>(<issue>2</issue>):<fpage>191</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1016/j.jpeds.2009.08.034</pub-id><pub-id pub-id-type="pmid">19846115</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwepcke</surname><given-names>A</given-names></name><name><surname>Weber</surname><given-names>FD</given-names></name><name><surname>Mormanova</surname><given-names>Z</given-names></name><name><surname>Cepissak</surname><given-names>B</given-names></name><name><surname>Genzel-Boroviczeny</surname><given-names>O</given-names></name></person-group>. <article-title>Microcirculatory mechanisms in postnatal hypotension affecting premature infants</article-title>. <source>Pediatr Res</source> (<year>2013</year>) <volume>74</volume>(<issue>2</issue>):<fpage>186</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1038/pr.2013.78</pub-id><pub-id pub-id-type="pmid">23802219</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goedhart</surname><given-names>PT</given-names></name><name><surname>Khalilzada</surname><given-names>M</given-names></name><name><surname>Bezemer</surname><given-names>R</given-names></name><name><surname>Merza</surname><given-names>J</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group>. <article-title>Sidestream Dark Field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation</article-title>. <source>Opt Express</source> (<year>2007</year>) <volume>15</volume>(<issue>23</issue>):<fpage>15101</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1364/OE.15.015101</pub-id><pub-id pub-id-type="pmid">19550794</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groner</surname><given-names>W</given-names></name><name><surname>Winkelman</surname><given-names>JW</given-names></name><name><surname>Harris</surname><given-names>AG</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name><name><surname>Bouma</surname><given-names>GJ</given-names></name><name><surname>Messmer</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Orthogonal polarization spectral imaging: a new method for study of the microcirculation</article-title>. <source>Nat Med</source> (<year>1999</year>) <volume>5</volume>(<issue>10</issue>):<fpage>1209</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1038/13529</pub-id><pub-id pub-id-type="pmid">10502828</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>AG</given-names></name><name><surname>Sinitsina</surname><given-names>I</given-names></name><name><surname>Messmer</surname><given-names>K</given-names></name></person-group>. <article-title>Validation of OPS imaging for microvascular measurements during isovolumic hemodilution and low hematocrits</article-title>. <source>Am J Physiol Heart Circ Physiol</source> (<year>2002</year>) <volume>282</volume>(<issue>4</issue>):<fpage>H1502</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1152/ajpheart.00475.2001</pub-id><pub-id pub-id-type="pmid">11893588</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathura</surname><given-names>KR</given-names></name><name><surname>Vollebregt</surname><given-names>KC</given-names></name><name><surname>Boer</surname><given-names>K</given-names></name><name><surname>De Graaff</surname><given-names>JC</given-names></name><name><surname>Ubbink</surname><given-names>DT</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group>. <article-title>Comparison of OPS imaging and conventional capillary microscopy to study the human microcirculation</article-title>. <source>J Appl Physiol</source> (<year>2001</year>) <volume>91</volume>(<issue>1</issue>):<fpage>74</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1152/jappl.2001.91.1.74</pub-id><pub-id pub-id-type="pmid">11408415</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genzel-Boroviczeny</surname><given-names>O</given-names></name><name><surname>Strotgen</surname><given-names>J</given-names></name><name><surname>Harris</surname><given-names>AG</given-names></name><name><surname>Messmer</surname><given-names>K</given-names></name><name><surname>Christ</surname><given-names>F</given-names></name></person-group>. <article-title>Orthogonal polarization spectral imaging (OPS): a novel method to measure the microcirculation in term and preterm infants transcutaneously</article-title>. <source>Pediatr Res</source> (<year>2002</year>) <volume>51</volume>(<issue>3</issue>):<fpage>386</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1203/00006450-200203000-00019</pub-id><pub-id pub-id-type="pmid">11861946</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidlich</surname><given-names>K</given-names></name><name><surname>Kroth</surname><given-names>J</given-names></name><name><surname>Nussbaum</surname><given-names>C</given-names></name><name><surname>Hiedl</surname><given-names>S</given-names></name><name><surname>Bauer</surname><given-names>A</given-names></name><name><surname>Christ</surname><given-names>F</given-names></name><etal/></person-group>
<article-title>Changes in microcirculation as early markers for infection in preterm infants &#x02013; an observational prospective study</article-title>. <source>Pediatr Res</source> (<year>2009</year>) <volume>66</volume>(<issue>4</issue>):<fpage>461</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1203/PDR.0b013e3181b3b1f6</pub-id><pub-id pub-id-type="pmid">19581833</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cevese</surname><given-names>A</given-names></name></person-group>
<article-title>Coronary circulation: nitric oxide and hypercapnic acidosis</article-title>. <source>Cardiovasc Res</source> (<year>2005</year>) <volume>66</volume>(<issue>1</issue>):<fpage>7</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.cardiores.2005.01.022</pub-id><pub-id pub-id-type="pmid">15769442</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fries</surname><given-names>M</given-names></name><name><surname>Weil</surname><given-names>MH</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Fang</surname><given-names>X</given-names></name><name><surname>Cammarata</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Increases in tissue Pco2 during circulatory shock reflect selective decreases in capillary blood flow</article-title>. <source>Crit Care Med</source> (<year>2006</year>) <volume>34</volume>(<issue>2</issue>):<fpage>446</fpage>&#x02013;<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1097/01.CCM.0000196205.23674.23</pub-id><pub-id pub-id-type="pmid">16424727</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hickling</surname><given-names>KG</given-names></name><name><surname>Joyce</surname><given-names>C</given-names></name></person-group>. <article-title>Permissive hypercapnia in ARDS and its effect on tissue oxygenation</article-title>. <source>Acta Anaesthesiol Scand Suppl</source> (<year>1995</year>) <volume>107</volume>:<fpage>201</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1111/j.1399-6576.1995.tb04359.x</pub-id><pub-id pub-id-type="pmid">8599278</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kluess</surname><given-names>HA</given-names></name><name><surname>Buckwalter</surname><given-names>JB</given-names></name><name><surname>Hamann</surname><given-names>JJ</given-names></name><name><surname>Clifford</surname><given-names>PS</given-names></name></person-group>. <article-title>Acidosis attenuates P2X purinergic vasoconstriction in skeletal muscle arteries</article-title>. <source>Am J Physiol Heart Circ Physiol</source> (<year>2005</year>) <volume>288</volume>(<issue>1</issue>):<fpage>H129</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1152/ajpheart.00574.2004</pub-id><pub-id pub-id-type="pmid">15374827</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komori</surname><given-names>M</given-names></name><name><surname>Takada</surname><given-names>K</given-names></name><name><surname>Tomizawa</surname><given-names>Y</given-names></name><name><surname>Nishiyama</surname><given-names>K</given-names></name><name><surname>Kawamata</surname><given-names>M</given-names></name><name><surname>Ozaki</surname><given-names>M</given-names></name></person-group>. <article-title>Permissive range of hypercapnia for improved peripheral microcirculation and cardiac output in rabbits</article-title>. <source>Crit Care Med</source> (<year>2007</year>) <volume>35</volume>(<issue>9</issue>):<fpage>2171</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1097/01.ccm.0000281445.77223.31</pub-id><pub-id pub-id-type="pmid">17855833</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malvin</surname><given-names>G</given-names></name></person-group>. <article-title>Microcirculatory effects of hypoxic and hypercapnic vasoconstriction in frog skin</article-title>. <source>Am J Physiol</source> (<year>1993</year>) <volume>264</volume>(<issue>2 Pt 2</issue>):<fpage>R435</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">8447501</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mazzoni</surname><given-names>MC</given-names></name><name><surname>Cragoe</surname><given-names>EJ</given-names><suffix>Jr</suffix></name><name><surname>Arfors</surname><given-names>KE</given-names></name></person-group>. <article-title>Systemic blood acidosis in low-flow ischemia induces capillary luminal narrowing</article-title>. <source>Int J Microcirc Clin Exp</source> (<year>1994</year>) <volume>14</volume>(<issue>3</issue>):<fpage>144</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1159/000178822</pub-id><pub-id pub-id-type="pmid">8082993</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGillivray-Anderson</surname><given-names>KM</given-names></name><name><surname>Faber</surname><given-names>JE</given-names></name></person-group>. <article-title>Effect of acidosis on contraction of microvascular smooth muscle by alpha 1- and alpha 2-adrenoceptors. Implications for neural and metabolic regulation</article-title>. <source>Circ Res</source> (<year>1990</year>) <volume>66</volume>(<issue>6</issue>):<fpage>1643</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1161/01.RES.66.6.1643</pub-id><pub-id pub-id-type="pmid">1971536</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>T</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Momma</surname><given-names>K</given-names></name></person-group>. <article-title>Effect of acidosis on contraction, intracellular pH and calcium in the rabbit mesenteric small artery</article-title>. <source>J Mol Cell Cardiol</source> (<year>1996</year>) <volume>28</volume>(<issue>8</issue>):<fpage>1715</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1006/jmcc.1996.0161</pub-id><pub-id pub-id-type="pmid">8877781</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakanishi</surname><given-names>T</given-names></name><name><surname>Gu</surname><given-names>H</given-names></name><name><surname>Momma</surname><given-names>K</given-names></name></person-group>. <article-title>Developmental changes in the effect of acidosis on contraction, intracellular pH, and calcium in the rabbit mesenteric small artery</article-title>. <source>Pediatr Res</source> (<year>1997</year>) <volume>42</volume>(<issue>6</issue>):<fpage>750</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1203/00006450-199712000-00006</pub-id><pub-id pub-id-type="pmid">9396553</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okazaki</surname><given-names>K</given-names></name><name><surname>Endou</surname><given-names>M</given-names></name><name><surname>Okumura</surname><given-names>F</given-names></name></person-group>. <article-title>Involvement of barium-sensitive K+ channels in endothelium-dependent vasodilation produced by hypercapnia in rat mesenteric vascular beds</article-title>. <source>Br J Pharmacol</source> (<year>1998</year>) <volume>125</volume>(<issue>1</issue>):<fpage>168</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1038/sj.bjp.0702048</pub-id><pub-id pub-id-type="pmid">9776357</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name></person-group>. <article-title>Hypercapnic acidosis activates KATP channels in vascular smooth muscles</article-title>. <source>Circ Res</source> (<year>2003</year>) <volume>92</volume>(<issue>11</issue>):<fpage>1225</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1161/01.RES.0000075601.95738.6D</pub-id><pub-id pub-id-type="pmid">12738754</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Backer</surname><given-names>D</given-names></name><name><surname>Donadello</surname><given-names>K</given-names></name><name><surname>Taccone</surname><given-names>FS</given-names></name><name><surname>Ospina-Tascon</surname><given-names>G</given-names></name><name><surname>Salgado</surname><given-names>D</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group>. <article-title>Microcirculatory alterations: potential mechanisms and implications for therapy</article-title>. <source>Ann Intensive Care</source> (<year>2011</year>) <volume>1</volume>(<issue>1</issue>):<fpage>27</fpage>.<pub-id pub-id-type="doi">10.1186/2110-5820-1-27</pub-id><pub-id pub-id-type="pmid">21906380</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brian</surname><given-names>JE</given-names><suffix>Jr</suffix></name><name><surname>Faraci</surname><given-names>FM</given-names></name><name><surname>Heistad</surname><given-names>DD</given-names></name></person-group>. <article-title>Recent insights into the regulation of cerebral circulation</article-title>. <source>Clin Exp Pharmacol Physiol</source> (<year>1996</year>) <volume>23</volume>(<issue>6&#x02013;7</issue>):<fpage>449</fpage>&#x02013;<lpage>57</lpage>.<pub-id pub-id-type="doi">10.1111/j.1440-1681.1996.tb02760.x</pub-id><pub-id pub-id-type="pmid">8800565</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wasserman</surname><given-names>AJ</given-names></name><name><surname>Patterson</surname><given-names>JL</given-names><suffix>Jr</suffix></name></person-group>
<article-title>The cerebral vascular response to reduction in arterial carbon dioxide tension</article-title>. <source>J Clin Invest</source> (<year>1961</year>) <volume>40</volume>:<fpage>1297</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="doi">10.1172/JCI104359</pub-id><pub-id pub-id-type="pmid">13783303</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buchele</surname><given-names>GL</given-names></name><name><surname>Ospina-Tascon</surname><given-names>GA</given-names></name><name><surname>De Backer</surname><given-names>D</given-names></name></person-group>. <article-title>How microcirculation data have changed my clinical practice</article-title>. <source>Curr Opin Crit Care</source> (<year>2007</year>) <volume>13</volume>(<issue>3</issue>):<fpage>324</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="doi">10.1097/MCC.0b013e3280c1e5c5</pub-id><pub-id pub-id-type="pmid">17468566</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Backer</surname><given-names>D</given-names></name><name><surname>Ospina-Tascon</surname><given-names>G</given-names></name><name><surname>Salgado</surname><given-names>D</given-names></name><name><surname>Favory</surname><given-names>R</given-names></name><name><surname>Creteur</surname><given-names>J</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group>. <article-title>Monitoring the microcirculation in the critically ill patient: current methods and future approaches</article-title>. <source>Intensive Care Med</source> (<year>2010</year>) <volume>36</volume>(<issue>11</issue>):<fpage>1813</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1007/s00134-010-2005-3</pub-id><pub-id pub-id-type="pmid">20689916</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perera</surname><given-names>P</given-names></name><name><surname>Kurban</surname><given-names>AK</given-names></name><name><surname>Ryan</surname><given-names>TJ</given-names></name></person-group>
<article-title>The development of the cutaneous microvascular system in the newborn</article-title>. <source>Br J Dermatol</source> (<year>1970</year>) <volume>82</volume>:<fpage>86</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2133.1970.tb07993.x</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genzel-Boroviczeny</surname><given-names>O</given-names></name><name><surname>Christ</surname><given-names>F</given-names></name><name><surname>Glas</surname><given-names>V</given-names></name></person-group>. <article-title>Blood transfusion increases functional capillary density in the skin of anemic preterm infants</article-title>. <source>Pediatr Res</source> (<year>2004</year>) <volume>56</volume>(<issue>5</issue>):<fpage>751</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1203/01.PDR.0000141982.38959.10</pub-id><pub-id pub-id-type="pmid">15347769</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genzel-Boroviczeny</surname><given-names>O</given-names></name><name><surname>Seidl</surname><given-names>T</given-names></name><name><surname>Rieger-Fackeldey</surname><given-names>E</given-names></name><name><surname>Abicht</surname><given-names>J</given-names></name><name><surname>Christ</surname><given-names>F</given-names></name></person-group>. <article-title>Impaired microvascular perfusion improves with increased incubator temperature in preterm infants</article-title>. <source>Pediatr Res</source> (<year>2007</year>) <volume>61</volume>(<issue>2</issue>):<fpage>239</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1203/pdr.0b013e31802d77a2</pub-id><pub-id pub-id-type="pmid">17237729</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stark</surname><given-names>MJ</given-names></name><name><surname>Clifton</surname><given-names>VL</given-names></name><name><surname>Wright</surname><given-names>IM</given-names></name></person-group>. <article-title>Sex-specific differences in peripheral microvascular blood flow in preterm infants</article-title>. <source>Pediatr Res</source> (<year>2008</year>) <volume>63</volume>(<issue>4</issue>):<fpage>415</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1203/01.pdr.0000304937.38669.63</pub-id><pub-id pub-id-type="pmid">18356749</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Backer</surname><given-names>D</given-names></name><name><surname>Ortiz</surname><given-names>JA</given-names></name><name><surname>Salgado</surname><given-names>D</given-names></name></person-group>. <article-title>Coupling microcirculation to systemic hemodynamics</article-title>. <source>Curr Opin Crit Care</source> (<year>2010</year>) <volume>16</volume>(<issue>3</issue>):<fpage>250</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1097/MCC.0b013e3283383621</pub-id><pub-id pub-id-type="pmid">20179590</pub-id></mixed-citation></ref></ref-list></back></article>